Economic regulation in the healthcare industry has long been a subject of debate, balancing the need for affordability, competition, and innovation. Understanding these regulations is essential, as they directly impact both current and future generations. This paper analyzes the economic implications of regulation within the U.S. Healthcare industry, pulling from specific historical scenarios to analyze the benefits and harms of various viewpoints. This includes FTC antitrust laws, market-based price controls, and more.

William Zhang
Editor, SPRING Editorials
International Academy Okma
Michigan, United States
William is a sophomore at International Academy Okma in Michigan and is interested in studying economics as well as the subjects in STEM. He loves to read, play games, and go on road trips. Outside of SPRING, he is the founder and captain of his school's debate team and participates in STEM competitions such as AMC and F=MA.
All Publications
As the world has slowly begun to resurface following the aftermath of COVID-19, health policies during the pandemic have also begun to draw attention regarding their effectiveness. Public health policies and pandemic prevention are topics of the utmost importance to the SPRING Group. This brief first provides the economic context from which COVID-19 rose, then provides a cost-benefit analysis of six national-level policies and 7 state-level policies and their economic implications.